It has been reported that the expression level of GPR34 is involved in marginal zone lymphoma, melanoma, and gastric cancer (Yu et al., 2013.
accepted by HISTOLOGY AND HISTOPATHOLOGY). However, it remains to be clarified how GPR34 functions in colorectal cancer. Methods: After the construction of stable GPR34 overexpression and knock-down LS174T colon cancer cell models, We employed GPR34 monoclonal antibody blocking, CCK-8 kit, colony formation assay, and subcutaneous transplant nude mouse model to characterize the effect of GPR34 on proliferation of LS174T in Vitro and xenograft tumor growth in PS 341 Vivo; Furthermore, immunoblot analysis of PI3K subunits and down-stream effectors assay were used to study its molecular mechanism(s) of action. Results: We showed that GPR34 involved in the proliferation of colon cancer cells in Vitro and tumor growth in Vivo. Both GPR34 overexpression and knockdown inhibit the proliferation of LS174T colon cancer cells and related xenograft tumor growth. Searching for the distinct molecular mechanism(s) responsible for GPR34′s anti-proliferation effect, we identified it contributes to proliferation of LS174T colon cancer cells through PI3Ks/Src/Ras/Raf/MEK1/ERK, and GPR34 overexpression inhibit the proliferation of LS174T
by down-regulating the expression of PI3K subunit p110-alpha and p85, and up-regulating the see more expression of p110-beta and p-PTEN, while GPR34 knock-down inhibit the proliferation of LS174T by up-regulating the expression of PI3K subunit p110-alpha, p85, and p-PTEN, and down-regulating the expression of p110-beta. Conclusion: Together, these data provide for the first time the direct evidence that supports a critical and fine role of GPR34/PI3K subunits pathway in the pathogenesis of colon cancer. Key Word(s): 1. GPR34; 2. Colon Cancer; 3. Proliferation; 4. PI3K Subunits; Presenting Author: JUNMING GUO Additional Authors: HAOJUN SONG, TIAN XIA, XIAOMING JIANG, YONGFU SHAO, BINGXIU XIAO Corresponding
Author: JUNMING GUO Affiliations: Ningbo Unversity Objective: Long learn more non-coding RNAs (lncRNAs) are prevalently transcribed in the genome yet their potential involvement in human cancers is not well understood. The aim of the present study was to determine the lncRNA expression profile in gastric cancer and its potential clinical value. Methods: The global lncRNA expression profile in gastric cancer was measured by lncRNA microarray. The level of two representative lncRNAs, H19 and uc001lsz, was confirmed and quantified by real-time quantitative reverse transcriptase-polymerase chain reaction (qRT-PCR). The relationship between their levels and clinicopathological factors of patients with gastric cancer was further explored. Results: Total of 71 and 64 lncRNAs were up and down regulated in gastric tumor tissues, respectively.
No related posts.